# Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis

> **NCT01563978** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 266 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** fostamatinib
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01563978
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 266 (ACTUAL)
- **Last updated:** 2014-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01563978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01563978, "Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01563978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*